Results 11 to 20 of about 155,757 (387)

[68Ga]Ga-PSMA-11 PET/CT in medullary thyroid carcinoma: comparison with [18F]FDG PET/CT and immunohistochemical analysis [PDF]

open access: yesFrontiers in Endocrinology
IntroductionMedullary thyroid carcinoma (MTC) is a rare neuroendocrine malignancy. Despite the use of various imaging modalities, including positron emission tomography combined with computed tomography (PET/CT), a significant proportion of patients with
Klaudia Zajkowska   +9 more
doaj   +2 more sources

Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25

open access: yesBritish Journal of Pharmacology, 2018
Debbie L Hay   +2 more
exaly   +2 more sources

Acetate-Mediated Odorant Receptor OR51E2 Activation Results in Calcitonin Secretion in Parafollicular C-Cells: A Novel Diagnostic Target of Human Medullary Thyroid Cancer

open access: yesBiomedicines, 2023
Medullary thyroid cancer originates from parafollicular C-cells in the thyroid. Despite successful thyroidectomy, localizing remnant cancer cells in patients with elevated calcitonin and carcinoembryonic antigen levels remains a challenge.
Hyeon Jeong Lee   +9 more
doaj   +1 more source

Aggressive clinical course of medullary thyroid microcarcinoma [PDF]

open access: yesMedicinski Glasnik Specijalne Bolnice za Bolesti Štitaste Žlezde i Bolesti Metabolizma "Zlatibor", 2022
Medullary thyroid carcinoma is a form of neuroendocrine tumor that arises from parafollicular C cells which produce calcitonin. In addition to calcitonin, these cells produce smaller amounts of other peptides, including carcinoembryonic antigen (CEA ...
Janić Tamara   +6 more
doaj   +1 more source

Calcitonin-secreting neuroendocrine neoplasms of the lung: a systematic review and narrative synthesis

open access: yesEndocrine Connections, 2021
Calcitonin-secreting neuroendocrine neoplasms of the lung are rare, with few cases reported in the literature. Differentiating between medullary th yroid carcinoma and an ectopic source of calcitonin secretion can represent a complex diagnostic conundrum
David C Llewellyn   +8 more
doaj   +1 more source

Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center

open access: yesFrontiers in Endocrinology, 2021
IntroductionMedullary thyroid carcinoma (MTC) is a rare cancer that accounts for 5% of thyroid cancers. Serum calcitonin is a good biomarker for MTC, which is used for diagnosis, prognosis, and monitoring of recurrence. Calcitonin-negative MTC (CNMTC) is
Sun Jung Kim   +4 more
doaj   +1 more source

Medullary thyroid cancer. Returning to the need to determine the preoperative basal calcitonin level in patients with thyroid nodular pathology [PDF]

open access: yesЭндокринная хирургия, 2019
There are International and Russian guidelines for the diagnosis and treatment of medullary thyroid carcinoma. There is a recommendation to determine the basal level of calcitonin for all patients with nodular thyroid disease at the all of these ...
Elena E. Stanyakina   +5 more
doaj   +1 more source

Beyond CGRP: The calcitonin peptide family as targets for migraine and pain

open access: yesBritish Journal of Pharmacology, 2021
The CGRP system has emerged as a key pharmacological target for the treatment of migraine. However, some individuals who suffer from migraine have low or no response to anti‐CGRP or other treatments, suggesting the need for additional clinical targets ...
Tayla A. Rees   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy